Syllabus · Historical · V4 (2023) · Cardiovascular System

G7 · Cardiovascular Pharmacology

G7.iv · Cardiovascular Pharmacology

Official V4 objective
Understand the pharmacology of anti-anginal drugs.
4 SAQ topics 8 SAQ appearances 0 VIVA stations
Current · V5 (2025) → D7.iii

Written examination

SAQ history

8 appearances
2020A Q02
Describe the pharmacology of Glyceryl trinitrate (GTN).
69%
2010A Q16
Define the mechanisms of action and adverse effects of metoprolol and glyceryl trinitrate when used to manage myocardial ischaemia.
80%
2025B Q09
Compare and contrast the following pharmacology of sodium nitroprusside and glyceryl trinitrate; (a) mechanism of action (25% of marks) (b) pharmacodynamics and toxicity (75% of marks). Treatment of toxicity is NOT required.
21%
2016B Q02
Compare and contrast the mechanisms of action and toxicity of sodium nitroprusside and glyceryl trinitrate (GTN).
55%
2008B Q20
Compare and contrast the pharmacology of sodium nitroprusside and glyceryl trinitrate.
—
2008A Q15
Compare and contrast the pharmacology of sodium nitroprusside and glyceryl trinitrate for the treatment of acute hypertension
66%
2020B Q20
Describe the pharmacology of intravenous sodium nitroprusside.
49%
2015A Q11
Outline the pharmacology of sodium nitroprusside (50% of marks). Discuss the mechanisms of toxicity and their management (50% of marks)
38%

Oral examination

VIVA history

0 stations

No mapped VIVA history for this objective.

Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.